We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Aurora Cannabis Inc | NASDAQ:ACB | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.23 | -3.30% | 6.74 | 6.74 | 6.76 | 7.30 | 6.64 | 7.04 | 6,056,373 | 21:21:05 |
From May 2019 to May 2024
Shareholder rights law firm Robbins LLP announces that a purchaser of Aurora Cannabis, Inc. (NYSE: ACB) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between October 23, 2018 and January 6, 2020. Aurora produces and distributes medical cannabis products.
If you suffered a loss as a result of Aurora' misconduct, click here.
Aurora Cannabis Inc. (ACB) Accused of Misleading Shareholders
According to the complaint, throughout the relevant period, due to Aurora's exaggerated representation of its market demand, the Company was overproducing consumer use cannabis products, leading to production inefficiencies. As a result, on November 14, 2019, Aurora released dismal fiscal first quarter 2020 financial results that revealed a revenue decline of 24% quarter-over-quarter with net income of $10.4 million, compared to net income of $104.2 million for the same quarter last year. Then, on November 29, 2019, Marijuana Business Daily reported that Germany had stopped the sale of Aurora's medical products while German authorities investigated Aurora's proprietary process. Following these issues, on December 21, 2019, Aurora announced the abrupt departure of its Chief Corporate Officer also described as Aurora's "public face." Finally, as a consequence of its poor financial condition, on January 6, 2020, Aurora announced that it would be selling one of its greenhouses to raise cash, marking the third tangible asset Aurora had decided to offload. Following all of these disclosures, Aurora shares traded at around just $1.83, representing a decline of almost 45% from its closing price of $3.29 on November 14, 2019.
Aurora Cannabis Inc. (ACB) Shareholders Have Legal Options
Contact us to learn more: Leo Kandinov (800) 350-6003 lkandinov@robbinsllp.com Shareholder Information Form
Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.
Attorney Advertising. Past results do not guarantee a similar outcome.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005785/en/
Leo Kandinov Robbins LLP 5040 Shoreham Place San Diego, CA 92122 lkandinov@robbinsllp.com (619) 525-3990 or Toll Free (800) 350-6003 www.robbinsllp.com
1 Year Aurora Cannabis Chart |
1 Month Aurora Cannabis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
